EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Amniotic fluid stem cell extracellular vesicles as a novel fetal therapy for pulmonary hypoplasia: a review on mechanisms and translational potential

Fabian Doktor iD, Lina Antounians, Rebeca Lopes Figueira, Kasra Khalaj iD, Miriam Duci iD, Augusto Zani

Stem Cells Translational Medicine · 2025

DOI: 10.1093/stcltm/szae095 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cells Translational Medicine, 2025. Verfasst von Fabian Doktor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, ON, Canada M5G 0…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Lung, Amniotic Fluid, Fetal Therapies. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disruption of developmental processes affecting the fetal lung leads to pulmonary hypoplasia. Pulmonary hypoplasia results from several conditions including congenital diaphragmatic hernia (CDH) and oligohydramnios. Both entities have high morbidity and mortality, and no effective therapy that fully restores normal lung development. Hypoplastic lungs have impaired growth (arrested branching morphogenesis), maturation (decreased epithelial/mesenchymal differentiation), and vascularization (endothelial dysfunction and vascular remodeling leading to postnatal pulmonary hypertension). Herein, we discuss the pathogenesis of pulmonary hypoplasia and the role of microRNAs (miRNAs) during normal and pathological lung development. Since multiple cells and pathways are altered, the ideal strategy for hypoplastic lungs is to deliver a therapy that addresses all aspects of abnormal lung development. In this review, we report on a novel regenerative approach based on the administration of extracellular vesicles derived from amniotic fluid stem cells (AFSC-EVs). Specifically, we describe the effects of AFSC-EVs in rodent and human models of pulmonary hypoplasia, their mechanism of action via release of their cargo, including miRNAs, and their anti-inflammatory properties. We also compare cargo contents and regenerative effects of EVs from AFSCs and mesenchymal stromal cells (MSCs). Overall, there is compelling evidence that antenatal administration of AFSC-EVs rescues multiple features of fetal lung development in experimental models of pulmonary hypoplasia. Lastly, we discuss the steps that need to be taken to translate this promising EV-based therapy from the bench to the bedside. These include strategies to overcome barriers commonly associated with EV therapeutics and specific challenges related to stem cell-based therapies in fetal medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesLungAmniotic FluidFetal TherapiesStem CellsLung DiseasesHumansAnimalsPregnancyMicroRNAsFemale

Stichwörter der Autor:innen

congenital diaphragmatic herniaexosomesfetal therapyinflammationregenerative therapystem cells

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, ON, Canada M5G 0A4.
  • Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, ON, Canada M5G 1X8.
  • Department of Pediatric Surgery, Leipzig University, Leipzig 04109, Germany.
  • Department of Surgery, University of Toronto, Toronto, ON, Canada M5T 1P5.

ORCID-Profile: Fabian Doktor, Kasra Khalaj, Miriam Duci

Zitieren

APA

Doktor, F., Antounians, L., Figueira, R. L., Khalaj, K., Duci, M., & Zani, A. (2025). Amniotic fluid stem cell extracellular vesicles as a novel fetal therapy for pulmonary hypoplasia: a review on mechanisms and translational potential. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szae095

Vancouver

Doktor F, Antounians L, Figueira RL, Khalaj K, Duci M, Zani A. Amniotic fluid stem cell extracellular vesicles as a novel fetal therapy for pulmonary hypoplasia: a review on mechanisms and translational potential. Stem Cells Translational Medicine. 2025. doi:10.1093/stcltm/szae095

BibTeX
@article{Doktor2025,
  author = {Doktor, Fabian and Antounians, Lina and Figueira, Rebeca Lopes and Khalaj, Kasra and Duci, Miriam and Zani, Augusto},
  title = {Amniotic fluid stem cell extracellular vesicles as a novel fetal therapy for pulmonary hypoplasia: a review on mechanisms and translational potential},
  journal = {Stem Cells Translational Medicine},
  year = {2025},
  doi = {10.1093/stcltm/szae095}
}
Kostenlos starten →